Is Vidoma C a Non Toxic Treatment?

The lack of financial reward, since vidaman c can't be patented and sold for a hundred thousand dollars could swade conventional investigators from seriously considering this approach. The mal clinic randomized control trials did not negate the potential benefit based on what we now know about the oral versus iv roots of administration. There are a highly poor polarized views on both sides, but everyone's working off the same incomplete data. We should revisit promising avenues without prejudice and with open mind.